PARSIPPANY, N.J.--(BUSINESS WIRE)--Natco Pharma Limited, a research and development (R&D)-focused pharmaceutical company based in India, today announced that DASH Pharmaceuticals, a company that ...

Stock Market Today: Natco Pharma share price gained more than 7% to scale 52 week highs on Thursday during the intraday trades. The robust US sales growth led by Revlimid generics is driving earnings.

Natco Pharma Ltd said on Monday it has agreed a deal with Gilead Sciences Inc to supply generic copies of the U.S. drugmaker's chronic hepatitis C medicines, including $1,000-a-pill drug Sovaldi ...

Natco Pharma Limited has received the final approval of its Abbreviated New Drug Application (ANDA) for lenalidomide capsules, 5mg, 10mg, 15mg, and 25mg strengths, from the US Food and Drug ...

Private equity firm CX Partners has revised its proposed deal with Hyderabad-based Natco Pharma, bringing its investment down by 30 per cent to Rs 108.5 crore. The PE firm, through its arm CX ...

Natco Pharma Limited shared that DASH Pharmaceuticals, a company that markets, sells and distributes generic pharmaceutical products, has officially transitioned to Natco Pharma USA, the U.S ...